Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2000
10/11/2000EP1042350A1 Inducible phosphofructokinase and the warburg effect
10/11/2000EP1042349A1 Using polyamide nucleic acid oligomers to engender a biological response
10/11/2000EP1042348A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes
10/11/2000EP1042347A1 Dna pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof
10/11/2000EP1042346A1 86 human secreted proteins
10/11/2000EP1042343A1 Vegi, an inhibitor of angiogenesis and tumor growth
10/11/2000EP1042342A1 53 human secreted proteins
10/11/2000EP1042000A1 Delivery of multiple genes to cells using plural adeno-associated viral vectors
10/11/2000EP1041882A1 Transvascular delivery of a composition to an extravascular tissue of a mammal
10/11/2000EP0719328B1 Grb3-3 gene, variants and uses thereof
10/11/2000CN1269832A Kay-novel immune system protein
10/11/2000CN1269804A CTL epitopes from EBV
10/11/2000CN1057301C Antioligonucleotide for inhibiting growth of tumor cells in humsanbody
10/10/2000US6130207 Genetic engineering
10/10/2000US6130206 Treating viral infections associated with chronic fatigue with dsRNA
10/10/2000US6130088 Antisense modulation of telomeric repeat binding factor 1 expression
10/10/2000US6130071 Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
10/10/2000US6130069 Nucleotide sequences coding a synthetase; for the diagnosis and treatment of bacterial infections; for the detection of agonist and antagonist of bacterial infection; bactericides
10/10/2000US6130067 Human EDG3sb gene
10/10/2000US6130066 Vectors having enhanced expression and methods of making and uses thereof
10/10/2000US6130062 Production of proteins in host cells
10/10/2000US6130060 Gene encoding for adseverin
10/10/2000US6130052 Leukemia associated genes
10/10/2000US6130051 Human insoitol monophosphatase H1
10/10/2000US6129911 Liver stem cell
10/10/2000CA2196797C In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene
10/10/2000CA2196790C 17q-linked breast and ovarian cancer susceptibility gene
10/10/2000CA2104396C Viral particles having altered host range
10/10/2000CA2080231C 2'-o-alkylnucleotides as well as polymers which contain such nucleotides
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058512A1 Antisense modulation of interleukin-5 signal transduction
10/05/2000WO2000058511A1 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
10/05/2000WO2000058506A2 Susceptibility to psoriasis
10/05/2000WO2000058501A2 Novel genetic suppressor elements and methods of making the same
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058488A2 Delivery of functional protein sequences by translocating polypeptides
10/05/2000WO2000058475A2 Streptococcus pneumoniae antigens
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058470A1 Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
10/05/2000WO2000058469A1 48 human secreted proteins
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058463A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000WO2000058460A2 Casb619 involved in colon cancers
10/05/2000WO2000058455A2 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
10/05/2000WO2000058451A1 Regulation of tyrosine hydroxylase expression
10/05/2000WO2000058441A1 STAPHYLOCOCCUS AUREUS ydjB RELATED TO THE LUXS AUTOINDUCER SYNTHESIS FAMILY
10/05/2000WO2000058358A1 49 human secreted proteins
10/05/2000WO2000058357A1 50 human secreted proteins
10/05/2000WO2000058356A1 50 human secreted proteins
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058336A1 50 human secreted proteins
10/05/2000WO2000058335A1 47 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058271A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000WO2000057922A1 Intramyocardial injection of autologous bone marrow
10/05/2000WO2000057921A2 Peroral gene therapy of diabetes and obesity
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057917A2 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
10/05/2000WO2000057915A1 Method of affecting cholesterol catabolism using nuclear bile acid receptor
10/05/2000WO2000057905A1 Recombinant neospora antigens and their uses
10/05/2000WO2000057900A2 Factor for regulation of neurite growth
10/05/2000WO2000057899A1 Thrombospondin-2 and uses thereof
10/05/2000WO2000057897A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000WO2000057890A1 Pulmonary delivery of protonated/acidified nucleic acids
10/05/2000WO2000057837A2 Compositions and methods for effecting the levels of cholesterol
10/05/2000WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors
10/05/2000WO2000029574A3 Inflammation-associated genes
10/05/2000WO2000029573A3 Adenoviral vectors
10/05/2000WO2000029033A3 A method of genetic vector delivery
10/05/2000WO2000029002A3 In utero transplantation of human mesenchymal stem cells
10/05/2000WO2000028060A3 Cells for the production of helper dependent adenoviral vectors
10/05/2000WO2000028039A3 Identification of senv genotypes
10/05/2000WO2000026379A3 Polypeptide mediating cell permeability
10/05/2000WO2000025804A3 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
10/05/2000WO2000023088A3 Methods of administering adenoviral vectors
10/05/2000DE19915178A1 Hepatitis C Virus Zellkultursystem Hepatitis C virus cell culture system
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2370441A1 50 human secreted proteins
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2369009A1 Factor for regulation of neurite growth
10/05/2000CA2368998A1 Delivery of functional protein sequences by translocating polypeptides
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368909A1 48 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368657A1 Thrombospondin-2 and uses thereof
10/05/2000CA2368641A1 Use of a lectin or conjugates for modulation of c-fibre activity
10/05/2000CA2368489A1 50 human secreted proteins
10/05/2000CA2368482A1 50 human secreted proteins
10/05/2000CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000CA2368469A1 50 human secreted proteins
10/05/2000CA2368467A1 50 human secreted proteins
1 ... 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 ... 870